ALLO
Allogene Therapeutics Inc
1.70$
-1.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -300.2% | -480.2% | -90,748.6% | -250,245.3% | -910,454.5% | – | |
| – | – | – | 19.8% | 27.2% | 5,882.7% | 14,946.3% | 61,995.5% | – | |
| – | – | – | 170.2% | 210.0% | 34,403.3% | 69,422.1% | 235,195.5% | – | |
| – | – | – | 180.5% | 210.0% | 38,729.2% | – | – | – | |
| – | – | – | 140.6% | -83.4% | 1,525.1% | -16,110.5% | -112,722.7% | – | |
| – | – | – | 172.0% | 55.7% | 2,136.2% | 1,595.8% | 3,154.5% | – | |
| – | – | – | -1,317.3% | 425.2% | 43,686.8% | 171,883.2% | 344,036.4% | – | |
| – | – | – | 7.4% | 9.4% | 1,012.8% | 2,590.5% | 6,977.3% | – | |
| – | – | – | 1,652.3% | 31.1% | 1,214.0% | 100,731.6% | 530,340.9% | – | |
| – | – | – | 34.9% | -23.9% | -45,847.7% | 22,369.5% | -36,077.3% | – | |
| – | – | – | -472.2% | -535.9% | -92,884.8% | -251,841.1% | -913,609.1% | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.